RxDoctor Payments Data

Taif Mukhdomi, MD

Anesthesiology · Flagstaff, AZNPI 1427583566

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.8%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Boston Scientific at 29.3% of the total. Among anesthesiology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,856in general payments, 2019–2025

Across 473 payments — averaging $56.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$8K
  • Medtronic$5K
  • Abbott$4K
  • Saluda Medical Americas, Inc.$2K
  • Nevro Corp.$1K
  • Spinal Simplicity, LLC$918
  • plus $4K from 28 others

What the payments were for

  • Grants$1,8757%
  • Travel & lodging$10,89041%
  • Food & beverage$13,91052%
  • Education$1811%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,856 in reported general payments places this provider in the 95th percentile of 1,166 anesthesiology providers in Arizona.

See all anesthesiology providers in Arizona

Medicare billing

Part B allowed, 2024
$274,402
Medicare patients
109
Services billed
6,121

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl65$54,479
Nurtec OdtRimegepant Sulfate14$27,133
Buprenorphine89$20,560
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen296$7,591
Doxepin Hcl12$6,500
Lidocaine28$6,195
ButransBuprenorphine16$4,371
Oxycodone Hcl236$4,219
Gabapentin264$4,198
Pregabalin104$4,149
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen211$3,695
Tizanidine Hcl379$3,462
Nortriptyline Hcl242$2,234
Celecoxib85$2,085
Buprenorphine Hcl80$1,772

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$755$54,47965 claims
PfizerNurtec Odt$69$27,13314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,166 anesthesiology providers in Arizona.

Other anesthesiology in Flagstaff

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →